Category: Provider Education

• Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?
• Fadda M, Chappuis PO, Katapodi MC, Pagani O, Monnerat C, Membrez V, Unger S, Caiata Zufferey M.
• PLoS One. 2020 Oct 8;15(10):e0240054. doi: 10.1371/journal.pone.0240054.

• PMID: 33031463
• PubMed abstract

• Free Full Text

• "I think that a brief conversation from their provider can go a very long way": Patient and provider perspectives on barriers and facilitators of genetic testing after ovarian cancer.
• Mallen AR, Conley CC, Fuzzell L, Ketcher D, Augusto BM, McIntyre M, Barton LV, Townsend MK, Fridley BL, Tworoger SS, Wenham RM, Vadaparampil ST.
• Support Care Cancer. 2020 Sep 25. doi: 10.1007/s00520-020-05779-1. Epub ahead of print.

• PMID: 32975643
• PubMed abstract
• Source abstract

• Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate Cancer.
• Scheinberg T, Goodwin A, Ip E, Linton A, Mak B, Smith DP, Stockler MR, Strach MC, Tran B, Young AL, Zhang AY, Mahon KL, Horvath LG.
• JCO Oncol Pract. 2020 Sep 24:OP2000399. doi: 10.1200/OP.20.00399. Epub ahead of print.

• PMID: 32970524
• PubMed abstract
• Source abstract

• The Impact of the Number of Tests Presented and a Provider Recommendation on Decisions about Genetic Testing for Cancer Risk.
• Schwartz MLB, Klein WMP, Erby LAH, Smith CH, Roter DL.
• Patient Educ Couns. 2020 Sep 18:S0738-3991(20)305188. doi: 10.1016/j.pec.2020.09.020. Epub ahead of print.

• Source abstract

• Implementing Cancer Genomics in State Health Agencies: Mapping Activities to an Implementation Science Outcome Framework.
• Green RF, Kumerow MT, Rodriguez JL, Addie S, Beachy SH, Senier L.
• Public Health Genomics. 2020 Sep 17:1-12. doi: 10.1159/000510336. Epub ahead of print.

• PMID: 32942283
• PubMed abstract
• Source abstract

Related:

Original research:

Proposed outcomes measures for state public health genomic programs.

• PMID: 29300382
• PubMed abstract
• Free Full Text

• Examining information-seeking behavior in genetic testing for cancer predisposition: a qualitative interview study.
• Zimmermann BM, Fanderl J, Koné I, Rabaglio M, Bürkic N, Shaw D, Elgera B.
• Patient Educ Couns. 2020 Sep 17:S0738-3991(20)305176. doi: 10.1016/j.pec.2020.09.019. Epub ahead of print.

• Source abstract

• Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?
• Alberty-Oller JJ, Weltz S, Santos A, Pisapati K, Ru M, Weltz C, Schmidt H, Port E.
• Ann Surg Oncol. 2020 Sep 11. doi: 10.1245/s10434-020-09123-z. Epub ahead of print.

• PMID: 32918176
• PubMed abstract
• Source abstract

• Genetic Testing Challenges in Oncology: Unnecessary Testing Identifies BRCA2 VUS in 16-Year-Old Girl.
• Ray T.
• Precision Oncology News. 2020 Sep 9.

• Press
• Free Full Text

• Ovarian cancer risk in Lynch syndrome: It’s time to individualize.
• Ring KL.
• BJOG. 2020 Sep 5. doi: 10.1111/1471-0528.16481. Epub ahead of print.

• Source abstract

• Commentary
• Free Full Text (PDF)

Related:

Original research:

A mismatch in care: results of a United Kingdom-wide patient and clinician survey of gynaecological services for women with Lynch syndrome

• PMID: 32725920
• PubMed abstract
• Free Full Text

• Strategies to enhance identification of hereditary breast cancer gene carriers.
• Reid S, Spalluto LB, Pal T.
• Expert Rev Mol Diagn. 2020 Aug 28. doi: 10.1080/14737159.2020.1816829. Epub ahead of print.

• PMID: 32856489
• PubMed abstract

• Editorial
• Free Full Text

• Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) for prophylactic bilateral salpingo-oophorectomy.
• Goldenberg M, Burke YZ, Matanes E, Lowenstein L.
• Surg Oncol. 2020 Aug 6;35:79-80. doi: 10.1016/j.suronc.2020.07.006. Epub ahead of print.

• PMID: 32846269
• PubMed abstract
• Source abstract

• Case report